HIGHLIGHTS
- who: Shenglan Li from the (UNIVERSITY) have published the Article: Signaling pathways in brain tumors and therapeutic interventions, in the Journal: (JOURNAL) of 16/Nov/2022
- what: This article showed that the octreotide and everolimus combination had a better anti-meningioma activity.308 PD-L1 and other immune checkpoint inhibitors in phase II clinical trials are being evaluated in high-grade and recurrent meningioma patients.
- future: Chimeric antigen receptor engineered-Natural Killer (CAR-NK) cells can be generated by chimeric antigen receptor technology and injected like T_cells to form a similar type of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.